Amneal Pharmaceuticals, Inc. (AMRX)
13.27
-0.03
(-0.23%)
USD |
NASDAQ |
Mar 05, 16:00
13.27
0.00 (0.00%)
After-Hours: 19:34
Amneal Pharmaceuticals Cash from Investing (Quarterly) : -45.45M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -6.146B |
| Corcept Therapeutics, Inc. | -11.84M |
| Apellis Pharmaceuticals, Inc. | -0.108M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 130.32M |
| Cash from Financing (Quarterly) | -10.12M |
| Free Cash Flow | 225.64M |
| Free Cash Flow Per Share (Quarterly) | 0.2565 |
| Free Cash Flow to Equity (Quarterly) | 80.82M |
| Free Cash Flow to Firm (Quarterly) | 134.62M |
| Free Cash Flow Yield | 5.24% |